INGELHEIM & HEIDELBERG, Germany--(BUSINESS WIRE)--Boehringer Ingelheim and BioMed X announced today that they have successfully applied a crowdsourcing approach to establish a research team of outstanding scientists from around the world with bright ideas, who will endeavor to identify new approaches for the treatment of patients with chronic obstructive pulmonary disease (COPD). COPD is a chronic, progressive, treatable but incurable lung disease affecting 210 million people worldwide. It is a
| < Prev | Next > |
|---|
